A Review of Cost-Effectiveness Analyses of Hypertension Treatment
- 1 April 1992
- journal article
- research article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 1 (4), 250-264
- https://doi.org/10.2165/00019053-199201040-00003
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Economic Evaluation of Drug TherapyPharmacoEconomics, 1992
- Meta-Analysis and Quality of Evidence in the Economic Evaluation of Drug TrialsPharmacoEconomics, 1992
- Pharmacoeconomic Evaluation of Risk Factors for Cardiovascular DiseasePharmacoEconomics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- Willingness to pay for antihypertensive therapy — results of a Swedish pilot studyJournal of Health Economics, 1991
- Cost-effectiveness analysis of hypertension treatment — A review of methodological issuesHealth Policy, 1991
- The costs of treating hypertension — an analysis of different cut-off pointsHealth Policy, 1991
- Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study.Hypertension, 1991
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- Clinical effectiveness and cost-effectiveness of monitoring blood pressure of hypertensive employees at work.Hypertension, 1983